Dr. Saurabh Agarwal joined St. John’s University in Fall 2018 as an Assistant Professor in the Department of Pharmaceutical Sciences within the College of Pharmacy and Health Sciences. Prior to joining St. John’s, Dr. Agarwal served as an Instructor Faculty at Baylor College of Medicine, Houston (2015-2018). Dr. Agarwal earned his Ph.D. in Biological Sciences from University of Lucknow, and M.S. in Biochemistry from Jiwaji University in India. Based on his doctoral research, Dr. Agarwal received French National Institute of Health and Medical Research (INSERM) Fellowship, and performed postdoctoral research at INSERM, Paris (2009-2010) on immunotherapy and cancer. Further, Dr. Agarwal completed another postdoctoral fellowship at Texas Children’s Cancer Center and Baylor College of Medicine, Houston (2011-2015), where he discovered a new cancer stem cell sub-population in neuroblastoma.
Dr. Agarwal published numerous high-impact and highly cited research publications, including publications in Nature Medicine, Journal of Experimental Medicine, Cancer Research, and Cancer Letters. Dr. Agarwal received numerous awards, recognitions, and philanthropy grants for his research including the St. Baldrick’s Foundation Scholar Career Development Award, David’s Warriors Hero Award, Wipe Out Kids’ Cancer Award, Villa Joep Foundation Research Excellence Award, and St. John’s University Venture Capital Fund Award, to name a few. Dr. Agarwal also serve as an Editorial Board Member for Journal of Brain Tumors & Neuro-oncology, and for Hematology and Blood Disorders. He also actively participates as reviewer for more than 20 high-impact research Journals.
Dr. Agarwal have active collaborations and is an Adjunct Assistant Professor at Baylor College of Medicine, and at Texas Children’s Cancer Center at Houston. He regularly participates and actively contribute in Institution’s education and research mission. Dr. Agarwal’s scholastic activities also include his regular participation and presentations in different local, national, and international conferences. Dr. Agarwal is an active member of American Association of Cancer Research (AACR), Advances in Neuroblastoma Research Association (ANRA), and American Association of Pharmaceutical Scientists (AAPS). Dr. Agarwal also participate in Research Fundraising events as guest speaker, and his research work is covered by different medical research media news.
Dr. Agarwal’s current research focuses on deciphering the biological and epigenetic mechanisms in pediatric cancer neuroblastoma. His main research interest is to develop effective targeted therapeutic approaches for neuroblastoma and for other cancers. Dr. Agarwal and his team discovered a novel cancer stem cell sub-population in neuroblastoma tumors and found that these cancer stem cells are responsible for cancer initiation, metastasis, drug-resistance, and relapse. He recently identified the role of cytokine G-CSF in enhancing tumorigenicity, metastasis, and relapse in neuroblastoma. His research leads to a major clinical trial for accessing safety of G-CSF use in neuroblastoma patients.
Currently Dr. Agarwal’s laboratory is developing effective therapeutic approaches to target cancer stem cells by identifying molecular and epigenetic factors responsible for maintaining these cells.
He established a cancer research laboratory at St. John’s and his research is well funded by the St. Baldrick’s Foundation, Wipe Out Kids Cancer Foundation, and by the St. John’s University.
*Interested students who would like to know more about Dr. Agarwal’s research and available opportunities in his lab should contact him directly by email.
Presentations in National and International Conferences: